The Big Pharma Corporatocracy and the Culture of Corruption

Recently by Karen De Coster: The Medical Establishment Fired Me for Rejecting Conventional Wisdom

If you never watch People & Power on Al Jazeera, here is a very interesting edition of the show from 2010 on "Drug Money." This is a very good film that exposes the lies and fraud of Big Pharma and the medical establishment (one and the same), though the film leaves out investigation of the enabler of this powerful oligarchy, which is government.

Turn to the 7:00 mark and note the interview with the whistleblower from Pfizer who was trained to lie, and when he asked too many questions about Bextra and its off-label marketing he was put on administrative leave. When he and four other whistleblowers were awarded $7.4 million from Pfizer in a legal settlement, the company "accepted full responsibility for improper past promotional practices" for Bextra, yet it denied the allegations made by those five individuals. The Bextra case is one of the largest drug settlements ever.

Also, at 13:00 of the video is the story of Risperdal, a drug marketed for the psychiatric industry for treating schizophrenia and other psychiatric "disorders." It has also been used to treat bipolar disorder children. Many male children developed breasts from using the drug. A professor from Harvard Medical School, Joseph Biederman, is the guy who spearheaded the effort "to fuel a controversial 40-fold increase from 1994 to 2003 in the diagnosis of pediatric bipolar disorder." A quote from a brief piece in the New York Times:

An inquiry by Senator Charles E. Grassley, Republican of Iowa, revealed last year that Dr. Biederman earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but failed to report all but about $200,000 of this income to university officials, according to information given Congressional investigators.

Court documents dating over several years that Dr. Biederman wants sealed show that he told the drug giant Johnson & Johnson that planned studies of its medicines in children would yield results benefiting the company.

By failing to report income, Dr. Biederman, and a colleague in the psychiatry department at Harvard Medical School, Dr. Timothy E. Wilens, may have violated federal and university research rules designed to police potential conflicts of interest. Some of their research is financed by government grants.

Biederman, who was also the director of the Johnson & Johnson Center for Pediatric Psychopathology Research at Massachusetts General Hospital in Boston, is described this way:

…The world’s most prominent advocate of diagnosing bipolar disorder in even the youngest children and of using antipsychotic medicines to treat the disease.

Read the rest of the article

January 12, 2012

Political Theatre

LRC Blog

LRC Podcasts